BEST MEDICAL INTERNATIONAL, INC., a Virginia Corporation; Best Vascular, Inc., a Delaware Corporation, Plaintiffs-Appellants, v. ECKERT & ZIEGLER NUCLITEC GMBH, a German corporation, successor to QSA Global GmbH, Defendant-Appellee, 602 F. App'x 125

Affirmed by unpublished PER CURIAM opinion. Unpublished opinions are not binding precedent in this circuit. PER CURIAM': Best Medical International, Inc. (“Best”) appeals the district court’s order granting Eckert & Ziegler Nuclitec GMBH’s (“EZN”) second motion for supplemental attorney’s fees, and a subsequent order denying Best’s Fed.R.Civ.P. 59(

e) motion. We have previously discussed the factual background and procedural history of this breach of contract case in our opinions in Best Med. Int’l, Inc. v. Eckert & Ziegler Nuclitec GMBH, 505 Fed.Appx. 281 (4th Cir.2013) and Best Med. Int’l, Inc. v. Eckert & Ziegler Nuclitec GMBH, 565 Fed.Appx. 282 (4th Cir.2014). In this third appeal, Best argues that the district court erred in awarding EZN supplemental attorney’s fees.

Specifically, Best contends that the merger doctrine under Virginia law precluded the additional award of attorney’s fees and that the award of attorney’s fees was not authorized by the Settlement Agreement. We have reviewed the parties’ briefs, the material submitted in the joint appendix, and the relevant case law, and find no reversible error in the district court’ award of supplemental attorney’s fees. Accordingly, we affirm for the reasons stated by the district court. Best Med. Int’l, Inc. v. Eckert & Ziegler Nuclitec GMBH, No. 1:10—cv-00617-CMH-IDD (E.D.

Va. filed July 24, 2014 & entered July 25, 2014; Sept. 5, 2014). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process. AFFIRMED. On appeal, Best does not challenge the reasonableness of the award.